FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for esomeprazole strontium from R2 Pharma, LLC, granting approval of this salt form under NDA 202342.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Peptic Ulcer Disease

Drugs mentioned

• Esomeprazole strontium (Esomeprazole strontium)

Snippet

SUPPL AP for ESOMEPRAZOLE STRONTIUM (ESOMEPRAZOLE STRONTIUM)